A decade after ophthalmologists adopted the use of electronic health records (EHRs), providers have been found to spend more time using EHR for an office visit, generate longer notes and close the chart faster, according to a study. Such changes may increase time and documentation pressure for providers.
A recent study suggests the use of Mohs micrographic surgery (MMS) for eyelid sebaceous carcinoma (SC) without orbital involvement to help prevent its recurrence. However, MMS has not succeeded in changing the long-term outcomes regarding metastasis or tumour-related mortality.
Patients with neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend protocol and who have tolerated some subretinal fluid (SRF) appear to achieve visual acuity (VA) outcomes similar to that of treatment aimed at resolving all SRF, according to a study.
Unintentional treatment interruptions in diabetic retinopathy patients, especially those with proliferative disease, managed with antivascular endothelial growth factor (anti-VEGF) therapy alone can result in irreversible blindness, as shown in a recent study.
In patients with acute central retinal vein occlusion, a history of systemic hypertension and presenting with worse visual acuity and a relative afferent pupillary defect predict the development of neovascular glaucoma, a retrospective study has shown.
A UK study has recently found that while adalimumab is clinically effective in uveitis associated with juvenile idiopathic arthritis (JIA), its cost-effectiveness compared with methotrexate alone in the UK setting is not demonstrated.
Parafoveal flow and vessel density (VD) are significantly reduced in individuals with early cognitive impairment and may serve as early biomarkers for Alzheimer’s disease (AD), according to a recent study.
High-dose cyclosporine A (CsA) cationic emulsion (CE) is well tolerated and effective in improving keratitis, symptoms and quality of life (QOL) in patients with severe vernal keratoconjunctivitis (VKC), according to a phase III study.
Presenting and best-corrected bilateral visual impairment (VI) and blindness are uncommon among Singaporeans, according to a new study. Important risk factors include the Malay ethnicity and advanced age and cataracts.